Gentex counsel granted shares, sells 9,024 stock

GENTEX CORP General Counsel Ryan Scott P reported multiple stock transactions in Gentex common shares.

Rhea-AI Filing Summary

GENTEX CORP General Counsel Ryan Scott P reported multiple stock transactions in Gentex common shares. He acquired 11,000 shares on February 19, 2026 and 25,782 shares on February 17, 2026 as grants, both at a stated price of $0.00 per share. The 25,782-share grant is performance-based, with the total tied to long-term incentives and vesting 100% three years from the grant date.

On February 17, 2026, he disposed of shares to cover tax obligations, delivering 11,492 shares and 2,907 shares at $24.89 per share. He also executed open-market sales of 7,145 shares and 1,879 shares at an average price of $24.7302 per share, totaling 9,024 shares sold. After these transactions, he directly owned 44,279 Gentex shares.

Insider Trade Summary

Net Seller: 9,024 shares

Net Sell 6 txns

Insider Ryan Scott P

Role General Counsel

Sold 9,024 shs ($223K)

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,000	$0.00	$0.00
Grant/Award	Common Stock	25,782	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	11,492	$24.89	$286K
Exercise Price or Tax Liability	Common Stock	2,907	$24.89	$72K
Sale	Common Stock	7,145	$24.7302	$177K
Sale	Common Stock	1,879	$24.7302	$46K

Holdings After Transaction: Common Stock — 55,279 shares (Direct)

Footnotes (3)

1. F1. 25,782 shares are performance-based shares where the total number of shares granted were based on long term performance incentives.
2. F2. Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan
3. F3. These shares vest 100% three years from grant award date.

FAQ

What insider transactions did Gentex (GNTX) General Counsel report?

Gentex General Counsel Ryan Scott P reported stock grants and disposals. He received 11,000 and 25,782 common shares as awards, then disposed of shares for taxes and sold 9,024 shares in open-market trades, ending with direct ownership of 44,279 shares.

How many Gentex (GNTX) shares did the General Counsel sell?

The General Counsel sold 9,024 Gentex common shares in open-market transactions. These sales occurred at an average price of $24.7302 per share, separate from additional shares delivered to cover tax liabilities associated with equity awards granted on February 17, 2026.

What stock awards did the Gentex (GNTX) General Counsel receive?

He received two common stock awards: 11,000 shares on February 19, 2026 and 25,782 shares on February 17, 2026. The 25,782-share award is performance-based, tied to long-term incentives, and is scheduled to vest 100% three years from the grant award date.

What was the purpose of the Gentex (GNTX) tax-withholding share disposals?

Two disposals of 11,492 and 2,907 Gentex shares were made to satisfy tax obligations. These tax-withholding transactions used shares valued at $24.89 each, allowing the insider to cover exercise price or tax liabilities without paying cash to the company.

How many Gentex (GNTX) shares does the General Counsel own after these transactions?

Following the reported grants, tax-related disposals, and open-market sales, the General Counsel directly owns 44,279 Gentex common shares. This figure reflects his remaining holdings after both acquiring performance-based awards and selling a portion of his vested stock.

Are any Gentex (GNTX) insider awards performance-based or subject to vesting?

Yes. The 25,782-share award reported by the General Counsel is performance-based, with the total tied to long-term performance incentives. According to the disclosure, these shares are scheduled to vest 100% three years from the grant award date, subject to conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ryan Scott P

(Last) (First) (Middle)

600 NORTH CENTENNIAL STREET

(Street)

ZEELAND MI 49464

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GENTEX CORP [ GNTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		A(1)		25,782	A	$0.00	67,702(2)	D
Common Stock	02/17/2026		F		11,492	D	$24.89	56,210	D
Common Stock	02/17/2026		F		2,907	D	$24.89	53,303	D
Common Stock	02/17/2026		S		7,145	D	$24.7302	46,158	D
Common Stock	02/17/2026		S		1,879	D	$24.7302	44,279	D
Common Stock	02/19/2026		A(3)		11,000	A	$0.00	55,279	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 25,782 shares are performance-based shares where the total number of shares granted were based on long term performance incentives.

2. Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan

3. These shares vest 100% three years from grant award date.

Remarks:

	/s/ Kevin Nash for Scott P. Ryan by Power of Attorney	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.